Related references
Note: Only part of the references are listed.The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2021)
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial
Pierpaolo Pellicori et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats
Atlante S. Mendes et al.
LIFE SCIENCES (2020)
Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure
Susan Stienen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure
Masatake Kobayashi et al.
ESC HEART FAILURE (2020)
Pappa2 deletion has sex- and age-specific effects on bone in mice
Julian K. Christians et al.
GROWTH HORMONE & IGF RESEARCH (2019)
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Min Zhao et al.
NATURE COMMUNICATIONS (2019)
Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study
Joao Pedro Ferreira et al.
CLINICAL RESEARCH IN CARDIOLOGY (2018)
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives
Bertram Pitt et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2017)
Aldosterone Production and Signaling Dysregulation in Obesity
Andrea Vecchiola et al.
CURRENT HYPERTENSION REPORTS (2016)
Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology
F. Jaisser et al.
PHARMACOLOGICAL REVIEWS (2016)
Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice
Vincent G. DeMarco et al.
HYPERTENSION (2015)
Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial
Frank Edelmann et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Matrix Metalloproteinase Enhances Big-Endothelin-1 Constriction in Mesenteric Vessels of Pregnant Rats With Reduced Uterine Blood Flow
Ali Abdalvand et al.
HYPERTENSION (2013)
A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells
Hideyuki Yamawaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Structural determinants of vascular endothelial growth factor-D receptor binding and specificity
Veli-Matti Leppanen et al.
BLOOD (2011)
The association of plasma resistin with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-Hydroxyvitamin D3 in human hypertension
Anand Vaidya et al.
CLINICAL ENDOCRINOLOGY (2011)
Caspase Inhibition Modulates Left Ventricular Remodeling Following Myocardial Infarction Through Cellular and Extracellular Mechanisms
William M. Yarbrough et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study
Wafae Iraqi et al.
CIRCULATION (2009)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk
N Peters et al.
EXPERIMENTAL CELL RESEARCH (2004)
Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome
JA Martignetti et al.
NATURE GENETICS (2001)
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure - Insights from the Randomized Aldactone Evaluation Study (RALES)
F Zannad et al.
CIRCULATION (2000)